A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

The phage therapy market is experiencing significant growth due to the increasing prevalence of antibiotic-resistant infections and the growing interest in alternative treatments. Advances in ...

DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.

Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer (“Biodexa” or “the Company”) ...

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...

Advancements in precision medicine drive the 5-HT2 agonist market by enabling selective targeting of specific receptor subtypes (e.g., 5-HT2A or 5-HT2C), reducing side effects and improving safety.

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...

GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development — an analysis that saved inestimable hours and dollars for the client. GATC West ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed ...